They conduct research in conjunction with the following institutes, centers, and labs.
Center for HIV-AIDS Vaccine Immunology (CHAVI)
CHAVI is a consortium of universities and academic medical centers that work together to solve major problems in HIV vaccine development and design. CHAVI is instrumental in connecting researchers from around the world and funding basic, translational, and clinical research initiatives that seek to develop this vaccine.
Center for Study of Aging and Human Development
The Center for Study of Aging and Human Development offers support, collaboration opportunities, and funding for researchers conducting biologic, clinical, social, and multidisciplinary research related to geriatric patients and their care.
Clinical Microbiology Laboratory
The clinical microbiology laboratory assists physicians and researchers by examining and culturing specimens for microorganisms, identifying important isolates, performing antibiotic susceptibility testing, and evaluating serological samples for infectious disease.
Duke Antibiotic Stewardship Outreach Network (DASON)
DASON is a collaboration funded by the Duke Endowment. It is a collaboration between Duke and 10 community hospitals and it aims to help community hospitals by developing an evidence-based, state-of-the art antimicrobial stewardship network. DASON uses an administrative model similar to that of an ongoing and highly successful infection control and prevention program, the Duke Infection Control Outreach Network (DICON).
Duke Center for AIDS Research (CFAR)
CFAR is committed to supporting HIV researchers who work to develop innovative preventive and therapeutic strategies to control and ultimately eradicate HIV infection. CFAR actively recruits researchers in other fields whose talent and interests could aid in HIV research and vaccine development, and also trains young basic and clinical scientists in how to conduct excellent research initiatives that will further the cause of medicine.
Duke Clinical Research Institute (DCRI)
DCRI and its staff provide the specialized facilities, training, and staff support that is necessary for our clinical research studies. The DCRI is the primary site for a number of prominent multi-center trials.
Duke Global Health Institute (DGHI)
DGHI engages researchers from various disciplines to solve complex health problems that affect the global community. As one of its signature research initiatives, the DGHI is supporting the study of emerging infectious disease. This initiative connects faculty involved in clinical and laboratory-based research to those studying economic and social factors related to emerging infectious diseases.
Duke Human Vaccine Institute (DHVI)
The Duke Human Vaccine Institute supports basic and translational research initiatives to create drugs, vaccines, and diagnostics that protect our society from AIDS, TB, plague, pandemic influenza, and other emerging infections.
Duke Infection Control Outreach Network (DICON)
DICON is a collaboration between Duke and 42 community hospitals. The purpose of the network is to improve infection control programs by compiling data on nosocomial infections at member hospitals, identifying trends and areas for improvement, and providing ongoing education and leadership to community providers.
DICON exists to help hospitals with limited resources develop state-of-the-art infection control programs and to give institutions with more sophisticated programs access to comparative statistics to support their infection control efforts. The primary focus of DICON is to improve outcomes for patients -- reducing the rate of health care associated infections and minimizing the costs associated with nosocomial and community-acquired infections.
Duke Malaria Collaboratory
Duke Malaria Collaboratory uses clinical and translational approaches to investigate the pathogenesis, transmission, and prevention of malaria.
Duke Program for Infection Prevention and Health Care Epidemiology
Duke Program for Infection Prevention oversees the operations, strategy and implementation of infection prevention practices at Duke University Hospital and its affiliated clinics. Our program is part of the CDC Prevention Epicenters program and carries research on the epidemiology, risk factors, outcomes and preventions
Duke Translational Medicine Institute (DTMI)
DTMI is an integrated support structure that provides resources and training and facilitates collaborative research in clinical and translational research.
Duke University AIDS Research and Treatment Center (DART)
DART provides outstanding HIV/AIDS patient care, fosters innovative but responsible clinical research, and trains medical practitioners in HIV/AIDS clinical care.
Duke Tri-I MMPTP
The Tri-Institutional Molecular Mycology and Pathogenesis Training Program (Tri-I MMPTP) is a multidisciplinary program spanning three major research universities that was created to recruit, support, and train promising postdoctoral scientists and physicians to develop productive research careers in molecular mycology and pathogenesis. The Tri-I MMPTP is the nation’s only NIH-funded training program dedicated to the numerous aspects of molecular mycology.